Back to Search
Start Over
Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.
- Source :
-
JAMA pediatrics [JAMA Pediatr] 2015 Jun; Vol. 169 (6), pp. 583-91. - Publication Year :
- 2015
-
Abstract
- Importance: Research has identified improved biomarkers of acute kidney injury (AKI). Cystatin C (CysC) is a better glomerular filtration rate marker than serum creatinine (SCr) and may improve AKI definition.<br />Objective: To determine if defining clinical AKI by increases in CysC vs SCr alters associations with biomarkers and clinical outcomes.<br />Design, Setting, and Participants: Three-center prospective cohort study of intensive care units in New Haven, Connecticut, Cincinnati, Ohio, and Montreal, Quebec, Canada. Participants were 287 patients 18 years or younger without preoperative AKI or end-stage renal disease who were undergoing cardiac surgery. The study dates were July 1, 2007, through December 31, 2009.<br />Exposures: For biomarker vs clinical AKI associations, the exposures were first postoperative (0-6 hours after surgery) urine interleukin 18, neutrophil gelatinase-associated lipocalin, kidney injury molecule 1, and liver fatty acid-binding protein. For clinical AKI outcome associations, the exposure was Kidney Disease: Improving Global Outcomes AKI definition (based on SCr or CysC).<br />Main Outcomes and Measures: Clinical AKI, length of stay, and length of mechanical ventilation. We determined areas under the receiver operating characteristic curve and odds ratios for first postoperative biomarkers to predict AKI.<br />Results: The SCr-defined vs CysC-defined AKI incidence differed substantially (43.6% vs 20.6%). Percentage agreement was 71% (κ = 0.38); stage 2 or worse AKI percentage agreement was 95%. Interleukin 18 and kidney injury molecule 1 discriminated for CysC-defined AKI better than for SCr-defined AKI. For interleukin 18 and kidney injury molecule 1, the areas under the receiver operating characteristic curve were 0.74 and 0.65, respectively, for CysC-defined AKI, and 0.66 and 0.58, respectively, for SCr-defined AKI. Fifth (vs first) quintile concentrations of both biomarkers were more strongly associated with CysC-defined AKI. For interleukin 18 and kidney injury molecule 1, the odds ratios were 16.19 (95% CI, 3.55-73.93) and 6.93 (95% CI, 1.88-25.59), respectively, for CysC-defined AKI vs 6.60 (95% CI, 2.76-15.76) and 2.04 (95% CI, 0.94-4.38), respectively, for SCr-defined AKI. Neutrophil gelatinase-associated lipocalin and liver fatty acid-binding protein associations with both definitions were similar. The CysC definitions and SCr definitions were similarly associated with clinical outcomes of resource use.<br />Conclusions and Relevance: Compared with the SCr-based definition, the CysC-based definition is more strongly associated with urine interleukin 18 and kidney injury molecule 1 in children undergoing cardiac surgery. Consideration should be made for defining AKI based on CysC in clinical care and future studies.
- Subjects :
- Child
Child, Preschool
Cohort Studies
Creatinine blood
Female
Heart Defects, Congenital blood
Humans
Infant
Intensive Care Units, Pediatric
Male
Postoperative Complications diagnosis
Predictive Value of Tests
Prospective Studies
Reference Values
Translational Research, Biomedical
Acute Kidney Injury blood
Acute Kidney Injury diagnosis
Biomarkers blood
Cystatin C blood
Heart Defects, Congenital surgery
Postoperative Complications blood
Subjects
Details
- Language :
- English
- ISSN :
- 2168-6211
- Volume :
- 169
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- JAMA pediatrics
- Publication Type :
- Academic Journal
- Accession number :
- 25844892
- Full Text :
- https://doi.org/10.1001/jamapediatrics.2015.54